세계의 군발성 두통 증후군 시장 보고서(2025년)

Cluster Headache Syndrome Global Market Report 2025

US $ 4,490 ￦ 6,301,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 9,108,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 11,914,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

군발성 두통 증후군 시장 규모는 향후 몇 년 동안 강력한 성장세를 보일 것으로 예상되며, 2029년까지 연평균 성장률(CAGR) 6.7%로 11억 1,000만 달러에 달할 것으로 예측됩니다. 예측 기간의 성장 배경에는 신경질환 유병률 증가, 신약 개발 투자 증가, 의료비 지출 증가, 우울증 환자 수 증가, 의약품 승인 건수 증가 등이 있습니다. 예측 기간의 주요 동향으로는 기술 발전, 원격 의료, 개인 맞춤형 의료, 신경 조절 기술, 표적 약물 요법 등을 들 수 있습니다.

신경 질환의 유병률 증가는 군발두통 증후군 시장의 성장을 가속할 것으로 예측됩니다. 신경질환에는 뇌, 척수, 전신 신경을 포함한 신경계에 영향을 미치는 다양한 질환이 포함됩니다. 신경질환 증가는 당뇨병과 같은 위험인자의 유병률 증가, 진단 능력의 향상, 다른 질환으로 인한 신경학적 합병증, 사회경제적 격차 등의 요인에 영향을 받고 있습니다. 신경질환의 치료는 이들 질환 중 일부가 두통 경로와 중복되거나 영향을 미치기 때문에 군발두통 증후군 관리에 도움이 될 수 있습니다. 군발두통의 증상과 근본적인 요인을 치료하면 군발두통의 빈도, 중증도, 영향을 효과적으로 줄일 수 있습니다. 예를 들어, 2022년 4월 벨기에에 본부를 둔 비영리 단체인 European Brain Council은 1,050만 명의 유럽인이 치매(신경질환)를 앓고 있으며, 이 숫자는 2050년까지 1,870만 명으로 증가할 것으로 예측했습니다. 따라서 신경질환의 유병률 증가가 군발두통증후군 시장을 주도하고 있습니다.

군발두통 증후군 시장의 주요 기업들은 보다 효과적인 치료 옵션을 제공하기 위해 이식형 신경 자극 시스템과 같은 첨단 기술 개발에 주력하고 있습니다. 이식형 신경자극 기술은 신경계의 특정 부위에 전기 자극을 공급하는 장치를 외과적으로 이식하는 기술입니다. 예를 들어, 2023년 8월 네덜란드에 본사를 둔 의료기기 회사 Salvia BioElectronics는 심한 편두통과 군발성 두통을 치료하기 위해 고안된 종이로 만든 얇은 신경자극기를 발표했습니다. 이 혁신적인 장치에는 초박형 생체 전자 호일이 포함되어 있으며, 일단 삽입되면 환자의 머리 모양에 맞게 조정되어 표적화된 전기 펄스를 공급합니다. 편두통과 군발성 두통은 특정 뇌 영역의 민감도 증가와 관련이 있기 때문에 이 장치에서 공급되는 전기 펄스는 균형을 회복하고 두통을 완화하는 데 도움이 됩니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 신형 코로나바이러스, 그리고 경기회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

• 세계 군발성 두통 증후군 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
• 최종 이용 산업 분석
• 세계의 군발성 두통 증후군 시장 : 성장률 분석
• 세계의 군발성 두통 증후군 시장 실적 : 규모와 성장, 2019-2024
• 세계의 군발성 두통 증후군 시장 예측 : 규모와 성장, 2024-2029, 2034F
• 세계 군발성 두통 증후군 전체 시장(TAM)

제6장 시장 세분화

• 세계의 군발성 두통 증후군 시장 : 유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 에피소드
• 만성
• 세계의 군발성 두통 증후군 시장 : 약제 유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• Calcium Channel Blockers
• Corticosteroids
• Sumatriptan
• Lithium Carbonate
• Ergots
• Melatonin
• Anti-Seizure
• Local Anesthetics
• 세계의 군발성 두통 증후군 시장 : 진단별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 신경학적 검사
• 자기공명영상
• 컴퓨터 단층촬영 스캔
• 세계의 군발성 두통 증후군 시장 : 투여 경로별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 경구
• 국소
• 정맥내
• 기타 투여 경로
• 세계의 군발성 두통 증후군 시장 : 유통 채널별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 병원 약국
• 소매 약국
• 온라인 스토어
• 기타 유통 채널
• 세계의 군발성 두통 증후군 시장 : 에피소드별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 단시간 발작성 빈발 두통
• 장기에 걸친 발작성 빈발 두통
• 세계의 군발성 두통 증후군 시장 : 만성질환별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 빈번한 발작을 수반하는 만성 빈발성 두통
• 보기 드문 발작을 수반하는 만성 빈발성 두통

제7장 지역별/국가별 분석

• 세계의 군발성 두통 증후군 시장 : 지역별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 세계의 군발성 두통 증후군 시장 : 국가별, 분석과 예측, 2019-2024, 2024-2029F, 2034F

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

• 군발성 두통 증후군 시장 : 경쟁 구도
• 군발성 두통 증후군 시장 : 기업 개요
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis
  • Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis
  • Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis

제31장 기타 주요 기업 및 혁신 기업

• Viatris Inc.
• Teva Pharmaceutical Industries Ltd.
• Otsuka Pharmaceutical Co. Ltd.
• Hikma Pharmaceuticals
• Amneal Pharmaceuticals
• Grunenthal GmbH
• Mallinckrodt Pharmaceuticals
• Upsher-Smith Laboratories
• Zogenix Inc.
• Neurelis Inc.
• ElectroCore Medical LLC
• Ceruvia Lifesciences
• TrioxBio Inc.
• Winston Pharmaceuticals Inc.
• Zosano Pharma Corporation

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

• 군발성 두통 증후군 시장(2029년) : 새로운 기회를 제공하는 국가
• 군발성 두통 증후군 시장(2029년) : 새로운 기회를 제공하는 부문
• 군발성 두통 증후군 시장(2029년) : 성장 전략
  • 시장 동향에 근거한 전략
  • 경쟁 전략

제36장 부록

LSH

영문 목차

영문목차

Cluster headache syndrome is a condition marked by severe, recurrent headaches that occur in clusters or episodes. These headaches are typically one-sided and extremely painful, often described as sharp, burning, or piercing sensations. They usually manifest around the eye or temple area and last between 15 minutes and three hours.

The main types of cluster headache syndrome are episodic and chronic. Episodic cluster headache features relatively long, pain-free remissions between headache episodes and is the more common type, affecting about 90% of those with the condition. Various medications used to treat cluster headaches include calcium channel blockers, corticosteroids, sumatriptan, lithium carbonate, ergots, melatonin, anti-seizure drugs, and local anesthetics. Diagnosis may involve neurological examination, magnetic resonance imaging (MRI), and computed tomography (CT) scans. Treatments can be administered orally, topically, intravenously, and through other methods, and are available through channels such as hospital pharmacies, retail pharmacies, online stores, and more.

The cluster headache syndromes market research report is one of a series of new reports from The Business Research Company that provides cluster headache syndromes market statistics, including cluster headache syndromes industry global market size, regional shares, competitors with a cluster headache syndromes market share, detailed cluster headache syndromes market segments, market trends, and opportunities, and any further data you may need to thrive in the cluster headache syndromes industry. This cluster headache syndromes research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The cluster headache syndrome market size has grown strongly in recent years. It will grow from $0.8 billion in 2024 to $0.85 billion in 2025 at a compound annual growth rate (CAGR) of 7.0%. The growth in the historic period can be attributed to a rise in public health initiatives, growth in research and development for headache treatments, increasing awareness of neurological disorders, growth in multinational clinical trials, and a rise in the availability of supportive therapies.

The cluster headache syndrome market size is expected to see strong growth in the next few years. It will grow to $1.11 billion in 2029 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to the rising prevalence of neurological disorders, rising investments in the development of new drugs, increasing healthcare spending, rising number of depression cases, and rising approval of drugs. Major trends in the forecast period include technological advancements, telemedicine, personalized medicine, neuromodulation techniques, and targeted drug therapies.

The increasing prevalence of neurological disorders is anticipated to drive the growth of the cluster headache syndrome market. Neurological disorders encompass a range of conditions affecting the nervous system, including the brain, spinal cord, and nerves throughout the body. The rise in neurological disorders is influenced by factors such as the growing prevalence of risk factors such as diabetes, improved diagnostic capabilities, neurological complications from other conditions, and socioeconomic disparities. Treatments for neurological disorders can help manage cluster headache syndrome, as some of these conditions overlap with or impact headache pathways. Addressing the symptoms and underlying factors of cluster headaches can effectively reduce their frequency, severity, and impact. For instance, in April 2022, the European Brain Council, a Belgium-based non-profit organization, reported that 10.5 million Europeans were affected by dementia (a neurological disorder), with this number expected to rise to 18.7 million by 2050. Therefore, the growing prevalence of neurological disorders is driving the cluster headache syndrome market.

Leading companies in the cluster headache syndrome market are focusing on developing advanced technologies, such as implantable neurostimulation systems, to offer more effective treatment options. Implantable neurostimulation technology involves surgically implanted devices that deliver electrical impulses to specific areas of the nervous system. For example, in August 2023, Salvia BioElectronics, a medical device company based in the Netherlands, introduced a paper-thin neuromodulation device designed to treat severe migraines and cluster headaches. This innovative device includes ultra-thin bioelectronic foils that adapt to the shape of the patient's head once implanted, delivering targeted electrical pulses. Since migraines and cluster headaches are associated with heightened sensitivity in certain brain areas, the electrical pulses provided by the device help restore balance and alleviate the headaches.

In October 2022, Emergex Vaccines Holding Limited, a UK-based biotechnology company, acquired the assets of Zosano Pharma Corporation, including intellectual property, license agreements, and manufacturing equipment, for an undisclosed amount. This acquisition enables Emergex to utilize Zosano's microneedle patch technology and manufacturing capabilities. Zosano Pharma Corporation is a US-based clinical-stage biopharmaceutical company specializing in developing treatments for cluster headache syndrome.

Major companies operating in the cluster headache syndrome market are Pfizer Inc., Bayer AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Viatris Inc., Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Hikma Pharmaceuticals, Amneal Pharmaceuticals, Grunenthal GmbH, Mallinckrodt Pharmaceuticals, Upsher-Smith Laboratories, Zogenix Inc., Neurelis Inc., ElectroCore Medical LLC, Ceruvia Lifesciences, TrioxBio Inc., Winston Pharmaceuticals Inc., Zosano Pharma Corporation, Autonomic Technologies Inc., H. Lundbeck A/S

North America was the largest region in the cluster headache syndrome market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cluster headache syndrome market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cluster headache syndrome market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cluster headache syndrome market consists of revenues earned by entities by providing services such as clinical services, specialized consultations, patient education programs, and support services. and related medical devices, microneedle patch technology, and diagnostic tools. The market value includes the value of related goods sold by the service provider or included within the service offering. The cluster headache syndrome market also includes sales of abortive medication, fast-acting analgesics, calcium channel blockers, corticosteroids, and anticonvulsants. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cluster Headache Syndrome Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cluster headache syndrome market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cluster headache syndrome ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cluster headache syndrome market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Episodic; Chronic
• 2) By Drug Type: Calcium Channel Blockers; Corticosteroids; Sumatriptan; Lithium Carbonate; Ergots; Melatonin; Anti-Seizure; Local Anesthetics
• 3) By Diagnosis: Neurological Examination; Magnetic Resonance Imaging; Computed Tomography Scan
• 4) By Route of Administration: Oral; Topical; Intravenous; Other Routes Of Administration
• 5) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Stores; Other Distribution Channels
• Subsegments:
• 1) By Episodic: Short-Duration Episodic Cluster Headaches; Long-Duration Episodic Cluster Headaches
• 2) By Chronic: Chronic Cluster Headaches With Frequent Attacks; Chronic Cluster Headaches With Rare Attacks
• Companies Mentioned: Pfizer Inc.; Bayer AG; GlaxoSmithKline plc; Takeda Pharmaceutical Company Limited; Eli Lilly and Company
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cluster Headache Syndrome Market Characteristics

3. Cluster Headache Syndrome Market Trends And Strategies

4. Cluster Headache Syndrome Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Cluster Headache Syndrome Growth Analysis And Strategic Analysis Framework

• 5.1. Global Cluster Headache Syndrome PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Cluster Headache Syndrome Market Growth Rate Analysis
• 5.4. Global Cluster Headache Syndrome Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Cluster Headache Syndrome Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Cluster Headache Syndrome Total Addressable Market (TAM)

6. Cluster Headache Syndrome Market Segmentation

• 6.1. Global Cluster Headache Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Episodic
• Chronic
• 6.2. Global Cluster Headache Syndrome Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Calcium Channel Blockers
• Corticosteroids
• Sumatriptan
• Lithium Carbonate
• Ergots
• Melatonin
• Anti-Seizure
• Local Anesthetics
• 6.3. Global Cluster Headache Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Neurological Examination
• Magnetic Resonance Imaging
• Computed Tomography Scan
• 6.4. Global Cluster Headache Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Topical
• Intravenous
• Other Routes Of Administration
• 6.5. Global Cluster Headache Syndrome Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Stores
• Other Distribution Channels
• 6.6. Global Cluster Headache Syndrome Market, Sub-Segmentation Of Episodic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Short-Duration Episodic Cluster Headaches
• Long-Duration Episodic Cluster Headaches
• 6.7. Global Cluster Headache Syndrome Market, Sub-Segmentation Of Chronic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chronic Cluster Headaches With Frequent Attacks
• Chronic Cluster Headaches With Rare Attacks

7. Cluster Headache Syndrome Market Regional And Country Analysis

• 7.1. Global Cluster Headache Syndrome Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Cluster Headache Syndrome Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cluster Headache Syndrome Market

• 8.1. Asia-Pacific Cluster Headache Syndrome Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Cluster Headache Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Cluster Headache Syndrome Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Cluster Headache Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cluster Headache Syndrome Market

• 9.1. China Cluster Headache Syndrome Market Overview
• 9.2. China Cluster Headache Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Cluster Headache Syndrome Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Cluster Headache Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cluster Headache Syndrome Market

• 10.1. India Cluster Headache Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Cluster Headache Syndrome Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Cluster Headache Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cluster Headache Syndrome Market

• 11.1. Japan Cluster Headache Syndrome Market Overview
• 11.2. Japan Cluster Headache Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Cluster Headache Syndrome Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Cluster Headache Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cluster Headache Syndrome Market

• 12.1. Australia Cluster Headache Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Cluster Headache Syndrome Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Cluster Headache Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cluster Headache Syndrome Market

• 13.1. Indonesia Cluster Headache Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Cluster Headache Syndrome Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Cluster Headache Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cluster Headache Syndrome Market

• 14.1. South Korea Cluster Headache Syndrome Market Overview
• 14.2. South Korea Cluster Headache Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Cluster Headache Syndrome Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Cluster Headache Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cluster Headache Syndrome Market

• 15.1. Western Europe Cluster Headache Syndrome Market Overview
• 15.2. Western Europe Cluster Headache Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Cluster Headache Syndrome Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Cluster Headache Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cluster Headache Syndrome Market

• 16.1. UK Cluster Headache Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Cluster Headache Syndrome Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Cluster Headache Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cluster Headache Syndrome Market

• 17.1. Germany Cluster Headache Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Cluster Headache Syndrome Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Cluster Headache Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cluster Headache Syndrome Market

• 18.1. France Cluster Headache Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Cluster Headache Syndrome Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Cluster Headache Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cluster Headache Syndrome Market

• 19.1. Italy Cluster Headache Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Cluster Headache Syndrome Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Cluster Headache Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cluster Headache Syndrome Market

• 20.1. Spain Cluster Headache Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Cluster Headache Syndrome Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Cluster Headache Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cluster Headache Syndrome Market

• 21.1. Eastern Europe Cluster Headache Syndrome Market Overview
• 21.2. Eastern Europe Cluster Headache Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Cluster Headache Syndrome Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Cluster Headache Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cluster Headache Syndrome Market

• 22.1. Russia Cluster Headache Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Cluster Headache Syndrome Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Cluster Headache Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cluster Headache Syndrome Market

• 23.1. North America Cluster Headache Syndrome Market Overview
• 23.2. North America Cluster Headache Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Cluster Headache Syndrome Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Cluster Headache Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cluster Headache Syndrome Market

• 24.1. USA Cluster Headache Syndrome Market Overview
• 24.2. USA Cluster Headache Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Cluster Headache Syndrome Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Cluster Headache Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cluster Headache Syndrome Market

• 25.1. Canada Cluster Headache Syndrome Market Overview
• 25.2. Canada Cluster Headache Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Cluster Headache Syndrome Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Cluster Headache Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cluster Headache Syndrome Market

• 26.1. South America Cluster Headache Syndrome Market Overview
• 26.2. South America Cluster Headache Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Cluster Headache Syndrome Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Cluster Headache Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cluster Headache Syndrome Market

• 27.1. Brazil Cluster Headache Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Cluster Headache Syndrome Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Cluster Headache Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cluster Headache Syndrome Market

• 28.1. Middle East Cluster Headache Syndrome Market Overview
• 28.2. Middle East Cluster Headache Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Cluster Headache Syndrome Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Cluster Headache Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cluster Headache Syndrome Market

• 29.1. Africa Cluster Headache Syndrome Market Overview
• 29.2. Africa Cluster Headache Syndrome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Cluster Headache Syndrome Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Cluster Headache Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cluster Headache Syndrome Market Competitive Landscape And Company Profiles

• 30.1. Cluster Headache Syndrome Market Competitive Landscape
• 30.2. Cluster Headache Syndrome Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis

31. Cluster Headache Syndrome Market Other Major And Innovative Companies

• 31.1. Viatris Inc.
• 31.2. Teva Pharmaceutical Industries Ltd.
• 31.3. Otsuka Pharmaceutical Co. Ltd.
• 31.4. Hikma Pharmaceuticals
• 31.5. Amneal Pharmaceuticals
• 31.6. Grunenthal GmbH
• 31.7. Mallinckrodt Pharmaceuticals
• 31.8. Upsher-Smith Laboratories
• 31.9. Zogenix Inc.
• 31.10. Neurelis Inc.
• 31.11. ElectroCore Medical LLC
• 31.12. Ceruvia Lifesciences
• 31.13. TrioxBio Inc.
• 31.14. Winston Pharmaceuticals Inc.
• 31.15. Zosano Pharma Corporation

32. Global Cluster Headache Syndrome Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cluster Headache Syndrome Market

34. Recent Developments In The Cluster Headache Syndrome Market

35. Cluster Headache Syndrome Market High Potential Countries, Segments and Strategies

• 35.1 Cluster Headache Syndrome Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Cluster Headache Syndrome Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Cluster Headache Syndrome Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer